HARTE HANKS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HARTE HANKS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.57M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $185.24M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $191.49M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $206.28M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $194.60M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $176.90M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $217.58M | Mar 24, 2021 |
| FY2017 | Dec 31, 2017 | $99.87M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $94.42M | Mar 15, 2018 |
| FY2017 | Jun 30, 2017 | $94.72M | Mar 15, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.57M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $185.24M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $191.49M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $206.28M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $194.60M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $176.90M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $217.58M | Mar 24, 2021 |
| FY2018 | Dec 31, 2018 | $70.21M | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | $63.59M | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | $69.63M | Mar 18, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($811.0K) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($30.30M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($1.57M) | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $36.78M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $14.97M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($1.69M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | ($26.26M) | Mar 24, 2021 |
| FY2018 | Dec 31, 2018 | $1.64M | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | ($9.98M) | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | ($6.73M) | Mar 18, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $386.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.09M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $3.36M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $15.11M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $7.64M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($10.58M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | ($21.61M) | Mar 24, 2021 |
| FY2018 | Dec 31, 2018 | ($4.34M) | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | ($10.35M) | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | ($6.31M) | Mar 18, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.21M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $22.78M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $20.67M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $21.89M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $17.86M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $21.52M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $24.29M | Mar 24, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.74M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($2.99M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $10.48M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $28.79M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($1.76M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($7.84M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $12.10M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($9.18M) | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | ($30.80M) | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $14.59M | Mar 15, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.76M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.75M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $2.81M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.80M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.05M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.70M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $2.90M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.21M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $5.68M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $6.69M | Mar 15, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.83M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $101.78M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $122.76M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $119.98M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $107.86M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $119.50M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $110.20M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $125.18M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $130.81M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $213.44M | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.30M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $80.09M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $102.90M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $101.18M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $122.85M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $162.90M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $150.16M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $134.64M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $165.45M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $210.78M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.53M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $21.69M | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | $19.86M | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | $18.81M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | ($24.72M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($53.12M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($49.68M) | Mar 21, 2022 |
| FY2020 | Dec 31, 2018 | ($19.18M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2017 | ($34.64M) | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | $2.66M | Mar 18, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.0K | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $295.0K | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.93M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $2.40M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 31, 2023 |
| FY2018 | Dec 31, 2018 | $0 | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $0 | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $34.51M | Mar 18, 2019 |
| FY2017 | Dec 31, 2015 | $69.70M | Mar 15, 2018 |
| FY2016 | Dec 31, 2014 | $248.89M | Jun 16, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $813.81M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $814.62M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $844.92M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $846.49M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $811.09M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $796.12M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $797.82M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $812.70M | Mar 19, 2020 |
| FY2018 | Jan 1, 2018 | $795.15M | Mar 18, 2019 |
| FY2018 | Dec 31, 2017 | $794.58M | Mar 18, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.58M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $9.81M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $18.36M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $10.36M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $11.91M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $29.41M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $28.10M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $20.88M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $8.40M | Mar 18, 2019 |
| FY2018 | Dec 31, 2016 | $46.01M | Mar 18, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $5.00M | Mar 21, 2022 |
| FY2021 | Dec 31, 2020 | $27.10M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | $18.70M | Mar 24, 2021 |
| FY2018 | Dec 31, 2017 | $0 | Mar 18, 2019 |
| FY2016 | Dec 31, 2016 | $0 | Jun 16, 2017 |
| FY2016 | Dec 31, 2015 | $77.11M | Jun 16, 2017 |
| FY2015 | Dec 31, 2014 | $82.69M | Mar 14, 2016 |
| FY2014 | Dec 31, 2013 | $98.00M | Mar 5, 2015 |
| FY2013 | Dec 31, 2012 | $110.25M | Mar 12, 2014 |
| FY2012 | Dec 31, 2011 | $179.44M | Mar 13, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 4 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | (4) | Mar 24, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | (1) | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | (1) | Mar 18, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 4 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | (4) | Mar 24, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Mar 18, 2019 |
| FY2018 | Sep 30, 2018 | (1) | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | (1) | Mar 18, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.41M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 7.36M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 7.22M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 7.40M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 6.98M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 6.60M | Mar 21, 2022 |
| FY2020 | Dec 31, 2019 | 6.30M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | 6.26M | Mar 19, 2020 |